164
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Multivariate Methods in the Development of a New Tablet Formulation: Optimization and Validation

, , , , &
Pages 1037-1049 | Published online: 11 Apr 2004

References

  • Wold S., Sjöström M., Carlson R., Lundstedt T., Hellberg S., Skagerberg B., Wikström C., Öhman J. Multivariate design. Anal. Chim. Acta 1986; 191: 17–32
  • Gabrielsson J., Lindberg N.‐O., Pålsson M., Nicklasson F., Sjöström M., Lundstedt T. Multivariate methods in the development of a new tablet formulation. Drug Dev. Ind. Pharm. 2003; 29(10)1053–1075
  • Peck G. E., Baley G. J., McCurdy V. E., Banker G. S. Tablet formulation and design. Pharmaceutical Dosage Forms2nd Ed., H. A. Lieberman, L. Lachman, J. B. Schwartz. Marcel Dekker, Inc., New York 1989
  • Pasikatan M. C., Steele J. L., Spillman C. K., Haque E. Near infrared reflectance spectroscopy for online particle size analysis of powders and ground materials. J. Near Infrared Spectrosc. 2001; 9(3)153–164
  • Rhodes C. T., Morisseau K. Tablet evaluation using near‐infrared spectroscopy. Encyclopedia of Pharmaceutical Technology, J. Swarbrick, J. C. Boylan. Marcel Dekker, Inc., New York 2002; Vol. 3: 2689–2700
  • Andre M. Multivariate analysis and classification of the chemical quality of 7‐aminocephalosporanic acid using near‐infrared reflectance spectroscopy. Anal. Chem. 2003; 75: 3460–3467
  • Gustafsson C., Nyström C., Lennholm H., Bonferoni M. C., Caramella C. M. Characteristics of hydroxypropyl methylcellulose influencing compactibility and prediction of particle and tablet properties by infrared spectroscopy. J. Pharm. Sci. 2003; 92(3)460–470
  • Website F., http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm
  • Lundstedt T., Seifert E., Abramo L., Thelin B., Nyström Å., Pettersen J., Bergman R. Experimental design and optimization. Chem. Intell. Lab. Sys. 1998; 42: 3–40
  • Harcum W. W., Skinner G. W., Altekar M., Joneja S. K., Barnum P. E., Guo J.‐H. Modeling the effects of hydroxypropylcellulose in acetaminophen tablet formulation. Drug Dev. Ind. Pharm. 1998; 24(10)911–918

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.